Jaguar Health (NASDAQ:JAGX) Stock Price Crosses Above 50-Day Moving Average – What’s Next?

Shares of Jaguar Health, Inc. (NASDAQ:JAGX) crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $1.02 and traded as high as $1.20. Jaguar Health shares last traded at $1.09, with a volume of 425,377 shares traded.

Wall Street Analyst Weigh In

Separately, StockNews.com upgraded shares of Jaguar Health from a “sell” rating to a “hold” rating in a research report on Friday, September 13th.

Jaguar Health Price Performance

The company has a quick ratio of 1.36, a current ratio of 1.84 and a debt-to-equity ratio of 1.65. The business’s 50-day moving average is $1.02 and its two-hundred day moving average is $1.52.

Institutional Trading of Jaguar Health

An institutional investor recently bought a new position in Jaguar Health stock. Virtu Financial LLC purchased a new position in shares of Jaguar Health, Inc. (NASDAQ:JAGX) during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 25,591 shares of the biotechnology company’s stock, valued at approximately $35,000. Virtu Financial LLC owned 0.22% of Jaguar Health as of its most recent SEC filing. Institutional investors and hedge funds own 12.04% of the company’s stock.

About Jaguar Health

Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products.